Efficacy of calcium hydroxide and resin-modified calcium silicate as pulp-capping materials: a retrospective study.

The aim of this study was to compare the clinical success rates of light-cured, resin-modified calcium silicate (TheraCal LC) and calcium hydroxide (Dycal) as pulp-capping materials in permanent teeth. In this retrospective electronic record review of patients treated in the years 2012 through 2015, the postoperative data of 120 patients (n = 60 per material) were collected. In these 2 groups, 69 teeth were treated with calcium hydroxide (29 in men, 40 in women) and 79 with calcium silicate (37 in men, 42 in women). The following data were recorded: treated tooth; patient age and sex; reason for treatment; direct or indirect pulp cap; date of treatment; date of most recent dental appointment; and treatment outcome. The selected patients met the following inclusion criteria: They had received either a direct or an indirect pulp cap in an anterior or posterior tooth after excavation of deep caries as part of a routine restorative procedure using either amalgam or composite resin; and they had returned to the clinic for other dental care at least 3 months after the pulp-capping treatment. Patients were excluded from the study if they reported symptoms of irreversible pulpitis or chronic tooth pain before the restorative treatment was started. The treatment outcome was considered clinically successful if the tooth was still present and asymptomatic at the appointments following the procedure. The outcome was considered unsuccessful if the tooth was extracted due to symptoms or if endodontic treatment had been performed postoperatively. There was no statistically significant difference between the clinical success rates of calcium silicate (85.5%) and calcium hydroxide (84.8%), according to the Fisher exact test (P < 0.05). Neither the patient's sex nor the tooth location affected the outcome. Within the limitations of this retrospective clinical study, it may be concluded that TheraCal LC calcium silicate can be considered equivalent inefficacy to calcium hydroxide for both direct and indirect pulp capping. A prospective clinical study with a larger sample size is needed to confirm these findings.